Washington, May 18, 2025 — U.S. President Joe Biden has been diagnosed with advanced prostate cancer with bone metastasis, according to an official statement released by the White House. The diagnosis came after the president experienced persistent urinary symptoms and underwent a series of medical evaluations, including a biopsy that confirmed a high-grade prostate adenocarcinoma with a Gleason score of 9 (Grade Group 5), indicating an aggressive form of the disease.
Doctors stated that the cancer is hormone-sensitive, allowing treatment with androgen deprivation therapy (ADT). Despite the advanced stage, the medical team assured the public that President Biden “remains functional” and will continue carrying out his official duties while undergoing treatment.
The announcement prompted widespread reactions from political leaders and the public. Former President Donald Trump initially expressed sympathy, calling the news “very sad.” However, he soon raised concerns about the timing and transparency of the disclosure, suggesting that the Biden administration should have informed the public sooner, especially during the 2024 election cycle. “We’re only hearing about this now, when treatment has already started. The American people deserve to know,” Trump said during a rally in Florida.
Donald Trump Jr. also commented, implying that members of Biden’s inner circle and family may have withheld the diagnosis from the public. His remarks were met with criticism from both political allies and opponents, including Republican commentator Meghan McCain, who urged for “dignity and privacy” in matters of serious illness.
Vice President Kamala Harris, whom Biden endorsed after withdrawing from the 2024 presidential race, expressed her support and called for “unity and compassion” as the president faces his health battle.
The situation has reignited public debate about medical transparency for sitting leaders and the need for clear protocols when serious health issues arise in elected officials.
